SciELO - Scientific Electronic Library Online

 
vol.3 número1APENDICITIS DEL MUÑON EN UN PACIENTE DE DOS AÑOS. REPORTE DE CASO Y REVISIÓN DE LA LITERATURAACCURATE DIAGNOSE AND MANAGEMENT OF ADVANCED NASAL TYPE EXTRANODAL NK/T CELL LYMPHOMA. A CASE REPORT índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Case reports

versión impresa ISSN 2462-8522

Resumen

MORANTES-CABALLERO, Jairo; CANO-ARENAS, Nairo  y  RODRIGUEZ DE NARVAEZ, Juan. REYNOLDS SYNDROME: A RARE RHEUMATOLOGIC DISEASE THAT INTERNISTS SHOULD HAVE IN MIND. CASE REPORT. Case reports [online]. 2017, vol.3, n.1, pp.30-41. ISSN 2462-8522.  https://doi.org/10.15446/cr.v3n1.59982.

Introduction:

Reynolds syndrome (RS) is an autoimmune disorder characterized by overlapping primary biliary cirrhosis (PBC) and limited cutaneous systemic sclerosis (lcSSc). Some published cases do not report pulmonary arterial hypertension (PAH), and diagnoses are usually based on clinical, immunological and histological findings, mainly focused on dermatologic features, on those associated with Sjogren's syndrome, or on an interesting presentation of malignant thymoma; only one case of reported PAH was found, but it was an image report.

Case Presentation:

This paper reports the case of a 75-year-old woman who presented with some of the features mentioned above, severe PAH, dyspnea for one month and two weeks of purulent expectoration, as well as generalized pruritus, nasal telangiectasias, Raynaud phenomenon, sclerodactyly, and high levels of alkaline phosphatase and transaminases.

Pulmonary arterial hypertension was documented through a transthoracic echocardiogram, and inmunoflorecence reported mitochondrial and centromere patterns of antinuclear-antibodies. Consequently, RS was diagnosed and phosphodiesterase type-5 inhibitors were started for PAH treatment resulting in the improvement of dyspnea.

Conclusion:

Dyspnea could be caused by many conditions, but in the presence of clinical and physical findings, it suggests an autoimmune disorder. Scleroderma should be considered and, additionally, PAH should be investigated since it is present in up to 10% of patients, conferring a worse prognosis. Internists should keep in mind that these disorders may be associated with other autoimmune diseases.

Palabras clave : Reynolds Syndrome; Scleroderma, Limited; Liver Cirrhosis, Biliary; Raynaud phenomenon; Hypertension; Pulmonary (MeSH).

        · texto en Inglés     · Inglés ( pdf )